ORIGINAL RESEARCH

Assessment of perioperative prophylaxis of infectious complications in post-op patients

About authors

Department of Clinical Pharmacology and Propedeutics of Internal Diseases, Faculty of General Medicine,
I.M. Sechenov First Moscow State Medical University, Moscow

Correspondence should be addressed : Maria V. Lukina
Bolshaya Pirogovskaya 2, str. 4, k. 106, Moscow, 119435; ur.xednay@0102kul-iram

About paper

Acknowledgements: the authors thank Oleg Babenko of Clinical Hospital No.1 of I.M. Sechenov First Moscow State Medical University for granting access to Hospital’s archived medical records.

Received: 2017-12-29 Accepted: 2018-03-23 Published online: 2018-04-30
|
  1. Aslanov BI, Zueva LP, Kolosovskaya EN, Lyubimova AV, Khoroshilov VYu, Dolgiy AA, et al. Printsipy organizatsii perioperatsionnoy antibiotikoprofilaktiki v uchrezhdeniyakh zdravookhraneniya. Federal'nye klinicheskie rekomendatsii. Moscow; 2014. 42 p. Russian.
  2. Gu Y, Kaku M. How can we fight against antimicrobial-resistant bacteria in the World Health Organization Western Pacific Region? Western Pac Surveill Response J. 2012 Jul 30; 3 (3): 40–2.
  3. Spellberg B, Gilbert DN. The future of antibiotics and resistance: a tribute to a career of leadership by John Bartlett. Clin Infect Dis. 2014 Sep 15; 59 Suppl 2: S71–5.
  4. Michael CA, Dominey-Howes D, Labbate M. The antimicrobial resistance crisis: causes, consequences, and management. Front Public Health. 2014 Sep 16; 2: 145.
  5. Bratzler DW, Dellinger EP, Olsen KM, Perl TM, Auwaerter PG, Bolon MK, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm. 2013 Feb 1; 70 (3): 195–283.
  6. Harbarth S, Samore MH, Lichtenberg D, Carmeli Y. Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance. Circulation. 2000 Jun 27; 101 (25): 2916–21.
  7. Kachroo S, Dao T, Zabaneh F, Reiter M, Larocco MT, Gentry LO, et al. Tolerance of vancomycin for surgical prophylaxis in patients undergoing cardiac surgery and incidence of vancomycin- resistant enterococcus colonization. Ann Pharmacother. 2006 Mar; 40 (3): 381–5.
  8. Yakovlev SV, Zhuravleva MV, Protsenko DN, Beloborodov VB, Briko NI, Brusina EB, et al. [Antibiotic stewardship program for inpatient care. Clinical guidelines for Moscow hospitals]. Consilium Medicum. 2017; 19 (7.1. Surgery): 15–51. Russian.
  9. Rasporyazhenie Pravitel'stva RF ot 25 sentyabrya 2017 g. № 2045-r «O Strategii preduprezhdeniya rasprostraneniya antimikrobnoy rezistentnosti v RF na period do 2030 g.». Order of the Government of the Russian Federation. Russian.
  10. ASHP therapeutic guidelines on antimicrobial prophylaxis in surgery. American Society of Health-System Pharmacists. Am J Health Syst Pharm. 1999 Sep 15; 56 (18): 1839–88.
  11. Khan AKA, Mirsh PV, Rashed MR, Banu G. A study on the usage pattern of antimicrobial agents for the prevention of surgical site infections (SSIs) in a tertiary care teaching hospital. J Clin Diagn Res. 2013 Apr; 7 (4): 671–4.
  12. Vessal G, Namazi S, Davarpanah MA, Foroughinia F. Evaluation of prophylactic antibiotic administration at the surgical ward of a major referral hospital, Islamic Republic of Iran. East Mediterr Health J. 2011 Aug; 17 (8): 663–8.
  13. El Hassan M, Elnour AA, Farah FH, Shehab A, Al Kalbani NM, Asim S, et al. Clinical pharmacists’ review of surgical antimicrobial prophylaxis in a tertiary hospital in Abu Dhabi. Int J Clin Pharm. 2015 Feb; 37 (1): 18–22.
  14. Gouvêa M, Novaes Cde O, Pereira DM, Iglesias AC. Adherence to guidelines for surgical antibiotic prophylaxis: a review. Braz J Infect Dis. 2015 Sep–Oct; 19 (5): 517–24.
  15. Prospero E, Barbadoro P, Marigliano A, Martini E, D'Errico M. Perioperative antibiotic prophylaxis: improved compliance and impact on infection rates. Epidemiol Infect. 2011 Sep; 139 (9): 1326–31.
  16. Implementation Manual WHO surgical safety checklist 2009. Safe surgery saves lives [file on the Internet]. Geneva, Switzerland: WHO; 2009 [cited 2017 Apr 10]: 20 p. Available from: http://apps. who.int/iris/bitstream/handle/10665/44186/9789241598590_ eng.pdf?sequence=1
  17. Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis. 2001 Apr 15; 32 (8): 1162–71.
  18. Rodríguez-Baño J, Picón E, Gijón P, Hernández JR, Cisneros JM, Peña C, et al. Risk factors and prognosis of nosocomial bloodstream infections caused by extended- spectrum-beta-lactamase-producing Escherichia coli. J Clin Microbiol. 2010 May; 48 (5): 1726–31.
  19. Greenstein AJ, Byrn JC, Zhang LP, Swedish KA, Jahn AE, Divino CM. Risk factors for the development of fulminant Clostridium difficile colitis. Surgery. 2008 May; 143 (5): 623–9.
  20. Grill MF, Maganti RK. Neurotoxic effects associated with antibiotic use: management considerations. Br J Clin Pharmacol. 2011 Sep; 72 (3): 381–93.
  21. Harris DG, McCrone MP, Koo G, Weltz AS, Chiu WC, Scalea TM, et al. Epidemiology and outcomes of acute kidney injury in critically ill surgical patients. J Crit Care. 2015 Feb; 30 (1): 102–6.
  22. Blot S, Lipman J, Roberts DM, Roberts JA. The influence of acute kidney injury on antimicrobial dosing in critically ill patients: are dose reductions always necessary? Diagn Microbiol Infect Dis. 2014 May; 79 (1): 77–84.